PVSP

Pervasip (PK) Stock Price

0.0046
0.00 (0.0%)
0.0046

Low
0.000001

52 Week Range

High
0.0399

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Pervasip Corp (PK) PVSP OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0046 11:10:22
Open Price Low Price High Price Close Price Prev Close
0.0046 0.0041 0.0049 0.0046
Bid Price Ask Price Spread News
0.0045 0.0046 0.0001 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
88 8,917,830 $ 0.004451 $ 39,691 - 0.000001 - 0.0399
Last Trade Time Type Quantity Stock Price Currency
11:10:22 455,390 $ 0.0046 USD

Pervasip (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.41M 5.31B -839.98M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
115.68k $ - 0.00% - -

more financials information »

Pervasip (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PVSP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00820.00850.00250.005617860,091,218-0.0036-43.9%
1 Month0.00450.03990.00250.006949983,057,9460.00012.22%
3 Months0.00050.03990.00030.0036885132,353,5150.0041820.0%
6 Months0.00010.03990.0000010.002692691,957,1600.00454,500.0%
1 Year0.000050.03990.0000010.002680258,480,4110.004559,100.0%
3 Years0.00010.03990.0000010.002352131,346,4490.00454,500.0%
5 Years0.00010.03990.0000010.002029123,830,2150.00454,500.0%

Pervasip (PK) Description

The word "Pervasip" is a contraction of the two words "pervasive psilocybin." Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungus. Research has shown that psilocybin has potential to treat a wide range of behavioral and psychiatric disorders. We formed a new subsidiary, Transcendence Age Corp., to study and provide health and wellness consulting for psilocybin treatments. To complement our efforts, we have made an investment in Kaiyon Inc., where we have purchased a 19.9% interest. We also provide business consulting and marketing services to public companies. More than 100 companies have purchased space on our website https://privateequitymarkets.us/. Our website features publicly traded companies and highlights the mining, technology, bio-tech, green-tech and cannabis industries. Services include free listings of press releases and a news feed.


Your Recent History
USOTC
PVSP
Pervasip (..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.